Back to search
FDAFDA · Food and drugs·Recall number D-1520-2016

Sennazon (sennosides) Syrup, 8.8 mg, 8 fl. oz. (237 mL) bottle, Mfd. for: Bayshore Pharmaceuticals, Tampla, FL 33619, NDC 76518-100-08.

Published October 5, 2016 · Recall initiated: August 8, 2016

Summary

FDA records drug Class II recall D-1520-2016, published October 5, 2016 and initiated August 8, 2016. Recalling firm: Pharmatech LLC; Status: Terminated; Reported quantity: 1,008 bottles; Lot: Lot #: 20391519, Exp 11/17. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Pharmatech LLC
Distributor
Nationwide
Lot
Lot #: 20391519, Exp 11/17
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Sennazon (sennosides) Syrup, 8.8 mg, 8 fl. oz. (237 mL) bottle, Mfd. for: Bayshore Pharmaceuticals, Tampla, FL 33619, NDC 76518-100-08. recalled?

Yes. FDA published recall D-1520-2016 on October 5, 2016. Reported hazard: CGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia.

What should I do if I have this product?

Voluntary: Firm initiated · Letter